Mehrdad Mobasher
San Francisco, California, United States
4K followers
500+ connections
San Francisco, California, United States
4K followers
500+ connections
About
Hematologist/Oncologist MD executive with 15+ years of clinical development research…
Articles by Mehrdad
-
Showcasing Our Leadership in Hematology at ASH 2023
Showcasing Our Leadership in Hematology at ASH 2023
By Mehrdad Mobasher
Activity
-
At BeiGene, Patients are our north star and we're honored to support partners like the International Waldenstrom's Macroglobulinemia Foundation…
At BeiGene, Patients are our north star and we're honored to support partners like the International Waldenstrom's Macroglobulinemia Foundation…
Liked by Mehrdad Mobasher
-
I’m pleased to have published an article in European Pharmaceutical Review reviewing decision-factors to be considered in the evolving #CLL treatment…
I’m pleased to have published an article in European Pharmaceutical Review reviewing decision-factors to be considered in the evolving #CLL treatment…
Shared by Mehrdad Mobasher
-
The FDA has granted BGB-16673 Fast Track Designation in R/R CLL. Very exciting news as we drive forward our commitment to exploring the promise of…
The FDA has granted BGB-16673 Fast Track Designation in R/R CLL. Very exciting news as we drive forward our commitment to exploring the promise of…
Shared by Mehrdad Mobasher
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
-
-
-
-
-
-
More activity by Mehrdad
-
I look forward to continue working with Mazyar Shadman, MD, MPH as he assumes his new role as medical director of the Bezos Family Immunotherapy…
I look forward to continue working with Mazyar Shadman, MD, MPH as he assumes his new role as medical director of the Bezos Family Immunotherapy…
Liked by Mehrdad Mobasher
-
"Cellular immunotherapy treatments, especially CAR T cells, are effective and have improved the clinical outcomes significantly but there is still…
"Cellular immunotherapy treatments, especially CAR T cells, are effective and have improved the clinical outcomes significantly but there is still…
Liked by Mehrdad Mobasher
-
The opening of our flagship U.S. manufacturing and clinical research and development facility in Hopewell, N.J. later this month is an important part…
The opening of our flagship U.S. manufacturing and clinical research and development facility in Hopewell, N.J. later this month is an important part…
Liked by Mehrdad Mobasher
-
I am thrilled to announce that I have taken on an exciting new challenge as the Vice President, Global Commercial Hematology Franchise Lead at…
I am thrilled to announce that I have taken on an exciting new challenge as the Vice President, Global Commercial Hematology Franchise Lead at…
Liked by Mehrdad Mobasher
-
We're thrilled to celebrate the success of the BeiGene #DEIB team in Australia and New Zealand and our inaugural event for #PrideMonth! 🌈 Our team…
We're thrilled to celebrate the success of the BeiGene #DEIB team in Australia and New Zealand and our inaugural event for #PrideMonth! 🌈 Our team…
Liked by Mehrdad Mobasher
-
#PrideMonth is a time to honor the history and achievements of the LGBTQIA+ community and raise awareness of the ongoing struggles its members are…
#PrideMonth is a time to honor the history and achievements of the LGBTQIA+ community and raise awareness of the ongoing struggles its members are…
Liked by Mehrdad Mobasher
-
I am joining my BeiGene colleagues from around the world at #EHA2024, as we share the latest advancements from our growing hematology…
I am joining my BeiGene colleagues from around the world at #EHA2024, as we share the latest advancements from our growing hematology…
Shared by Mehrdad Mobasher
-
#News for #Investors and #Media: As the chronic lymphocytic leukemia (CLL) treatment landscape continues to evolve, it’s important to provide new…
#News for #Investors and #Media: As the chronic lymphocytic leukemia (CLL) treatment landscape continues to evolve, it’s important to provide new…
Liked by Mehrdad Mobasher
-
BeiGene’s presence at #ASCO24 is a testament to our commitment to developing treatments that address the unmet needs of patients with B-cell…
BeiGene’s presence at #ASCO24 is a testament to our commitment to developing treatments that address the unmet needs of patients with B-cell…
Shared by Mehrdad Mobasher
-
Check out the latest issue of Blood, the Journal of the American Society of Hematology, for a preclinical publication characterizing our potent and…
Check out the latest issue of Blood, the Journal of the American Society of Hematology, for a preclinical publication characterizing our potent and…
Liked by Mehrdad Mobasher
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More